To confirm the result of the TCGA-GBM cohort, we also observed expression of USP6NL in our SHH-GBM cohort, where the specimens were evaluated by relatively comparable pathologists (Cohen’s Kappa 0.78), as delineated in Supplementary Table S3. The gene discussed is USP6NL; the disease is glioblastoma.